Intech Investment Management LLC decreased its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 66.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,903 shares of the company’s stock after selling 42,545 shares during the quarter. Intech Investment Management LLC’s holdings in McKesson were worth $18,701,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. BlackRock Inc. purchased a new position in McKesson during the 2nd quarter worth $8,156,743,000. Bank of America Corp DE acquired a new position in McKesson in the second quarter valued at $998,896,000. Legal & General Group Plc purchased a new stake in shares of McKesson in the second quarter valued at about $656,566,000. The Manufacturers Life Insurance Company purchased a new stake in shares of McKesson in the second quarter valued at about $651,462,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of McKesson in the second quarter valued at about $599,060,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
McKesson Price Performance
NYSE:MCK opened at $1,103.31 on Monday. The firm has a market cap of $127.39 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 1.86 and a beta of 0.27. The firm’s fifty day moving average price is $955.45 and its 200 day moving average price is $874.53. McKesson Corporation has a 1-year low of $723.68 and a 1-year high of $1,121.50.
McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, topping analysts’ consensus estimates of $10.72 by $0.96. The company had revenue of $110.96 billion during the quarter, compared to the consensus estimate of $109.90 billion. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. McKesson’s quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $9.86 EPS. As a group, analysts expect that McKesson Corporation will post 46.16 earnings per share for the current fiscal year.
McKesson Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be paid a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Tuesday, December 1st. McKesson’s payout ratio is 9.67%.
Insider Transactions at McKesson
In other news, EVP Francisco Fraga sold 800 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the transaction, the executive vice president directly owned 5,423 shares in the company, valued at $5,400,223.40. The trade was a 12.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares of the company’s stock, valued at $464,445.45. This represents a 17.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 2,161 shares of company stock worth $2,242,515. Company insiders own 0.06% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on MCK. Weiss Ratings upgraded shares of McKesson from a “buy (b)” rating to a “buy (b+)” rating in a research note on Monday, November 9th. Robert W. Baird set a $1,015.00 price target on McKesson in a research report on Thursday, August 6th. Royal Bank Of Canada boosted their price target on McKesson from $845.00 to $965.00 and gave the company a “sector perform” rating in a research report on Thursday, November 5th. Citigroup upped their price objective on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Finally, Wells Fargo & Company increased their price objective on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average target price of $1,040.29.
Check Out Our Latest Research Report on McKesson
About McKesson
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.
Featured Stories
- Five stocks we like better than McKesson
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
